Advertisement

Topics

Living Cell Technologies: New Technologies and Clinical Trials

19:00 EST 19 Jan 2010 | PharmaTelevision

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies.

Filmed at AusBiotech 2009, they discuss:

• The company’s origins and aims
Pig islet transplantation to combat diabetes
• Results of Russian and New Zealand clinical trials
• Living Cell Technologies’ issues with clinical trials in Australia
• The company’s search for a clinical service partner

Original Article: Living Cell Technologies: New Technologies and Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "Living Cell Technologies: New Technologies and Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...